Outcomes following treatment of femoropopliteal in‐stent restenosis: A single center experience

作者
Khung Keong Yeo,Umer Feroze Malik,John R. Laird
出处
期刊:Catheterization and Cardiovascular Interventions [Wiley]
卷期号:78 (4): 604-608 被引量:46
标识
DOI:10.1002/ccd.23022
摘要

OBJECTIVES: The aim of this study is to describe a single-center experience with endovascular treatment of femoropopliteal in-stent restenosis (ISR). BACKGROUND: Femoropopliteal artery stenting is associated with a significant risk of ISR. Data are limited on the optimal treatment strategy and associated outcomes. METHODS: A single institution retrospective chart review study was performed for patients who underwent endovascular treatment of femoropopliteal ISR from January 2006 to October 2008. Clinical and procedural characteristics, angiographic findings, and 12-month primary and secondary patency rates were analyzed. Univariate analysis was performed to identify predictors of 12-month primary patency. RESULTS: Twenty-two limbs were treated in 20 patients during the study period. Procedural success was achieved in 21 limbs (95.5%). Laser, balloon angioplasty, and excisional atherectomy were the primary therapy in 52.4%, 33.3%, and 14.3% of the cases, respectively. Adjunctive balloon angioplasty was performed after laser and excisional atherectomy in all cases. The mean length of ISR was 13.2 ± 11.3 cm with a significant proportion of cases (40.9%) having Type IV pattern of ISR. At 12 months, primary and combined primary-assisted and secondary patency rates were 47.6 and 61.9%, respectively. Of the 11 limbs that did not have secondary patency, 6 had mild or no symptoms, and, therefore, repeat intervention was not performed. There was one transmetatarsal amputation during the 12-month follow-up period. In this study, there was no significant predictor of 12-month primary patency. CONCLUSIONS: Treatment of ISR remains challenging with significant risk of recurrent restenosis. Further research is required to improve long-term patency.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
David完成签到,获得积分10
刚刚
刚刚
乐乐的应助被小猪采纳,获得10
1秒前
夏夏完成签到,获得积分10
1秒前
Vv关注了科研通微信公众号
2秒前
圈圈完成签到 ,获得积分10
2秒前
Owo完成签到 ,获得积分10
2秒前
晚风完成签到,获得积分10
3秒前
桐桐的应助被做错了范采纳,获得10
4秒前
初景发布了新的文献求助10
4秒前
xwy发布了新的文献求助10
4秒前
senger发布了新的文献求助10
4秒前
梨花诗完成签到,获得积分20
4秒前
xing_xing的应助被吱吱吱采纳,获得20
5秒前
YHY发布了新的文献求助10
5秒前
幸运星完成签到,获得积分10
5秒前
syvshc的应助被小黑球采纳,获得10
5秒前
5秒前
阿九发布了新的文献求助10
6秒前
风中的小鸽子完成签到 ,获得积分10
6秒前
万能图书馆的应助被Code_king采纳,获得10
6秒前
6秒前
思源的应助被XXQ采纳,获得10
6秒前
qeyqor完成签到,获得积分10
7秒前
7秒前
科研通AI65的应助被cgl155410采纳,获得20
7秒前
慕青的应助被称心学姐采纳,获得10
7秒前
lpp完成签到,获得积分10
8秒前
8秒前
芷云完成签到,获得积分10
8秒前
乐乐的应助被hh采纳,获得10
8秒前
8秒前
8秒前
8秒前
YIXIAO关注了科研通微信公众号
9秒前
脑洞疼的应助被333采纳,获得10
9秒前
甜甜大炮发布了新的文献求助10
10秒前
bkagyin的应助被疯狂的枫叶采纳,获得10
10秒前
ding的应助被xiaohai1466采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176102
求助须知:如何正确求助?哪些是违规求助? 9567588
关于积分的说明 21793477
捐赠科研通 7770603
什么是DOI,文献DOI怎么找? 3431969
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477522